课题基金 / 基金详情

Effects of peptides in the hypothalamic vasopressinergic nuclei.

Effects of peptides in the hypothalamic vasopressinergic nuclei.
肽在下丘脑加压素能核中的作用。
批准号:
01480142
负责人:
MATSUDA Tomohiro
金额:
$1.66万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (B)
财政年份:
1989
资助国家:
日本
项目状态:
已结题
起止时间:
1989 至 1991

项目摘要

项目成果

MATSUDA Tomohiro的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
1) Muscarinic agonist, oxotremorine microinjected into the hypothalamic vasopressinergic nucleus (the supraoptic nucleus or the paravetricular nuleus) induced potent antidiuretic effects which were associated with increases in the level of plasma vasopressin. The antidiuretic effects were completely blocked by premicroinjection of muscarinic antagonist, atropine or by preteartment with intravenous injection of vasopressin (V1+V2) receptor antagonist, d (CH2) 5-D-Tyr (Et) -VAVP.2) Neuropeptide, substance P also caused potent antidiuretic effects, when microinjected into the supraoptic nucleus. At the maximal effects of substance P, vasopressin concentration in the urine increased up to approximately 26-fold the control value. Premicroinjection of substance P receptor antagonist, spantide inhibited the antidiuretic effects of substance P. Substance P microinjected into the paraventricular nucleus also demonstrated potent antidiuretic effects.3) A kappa-type opioid peptide, dynorphin (1-13) which colocalizes with vasopressin induced potent antidiuretic effects which accompanied in-creases in the plasma level of vasopressin, when injected into the supraoptic nucleus or the paraventricular nucleus. The effects of the supraoptic injection were inhibited by premicroinjection of naloxone, but were not the effects of the paraventricular injection. Dynophin (2-13) which does not bind to opioid receptors induced approximately equipotent effects to dynorphin (1-13) when injected in the supraoptic nucleus, and it induced much less potent effects than dynorphin (1-13), when injected into the paravetricular nucleus.The results indicate that the stimulation of muscarinic or substance P -receptors in the nuclei by specific agonists induced the release of vasopressin, and that dynorphin (1-13) stimulated the neurons in the paraventricular nucleus through opioid receptors and it stimulated neurons in the supraoptic nucleus via non-opioid receptors, to release vasopressin.
期刊论文(64)
专著(0)
科研奖励(0)
会议论文
森 眞由美,津島 宏美,松田 友宏: "視床下部バゾプレッシンニュ-ロン神経核(視索上核)におけるサブスタンスPとそのアナログの作用" 神経化学. 28. 266-267 (1989)
Mayumi Mori、Hiromi Tsushima、Tomohiro Matsuda:“P 物质及其类似物对下丘脑加压素神经元核(视上核)的影响”《神经化学》28. 266-267 (1989)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Hiromi Tsushima,Mayumi Mori,and Tomohiro Matsuda: "Effects of dynorphin,injected into the hypothalamic supraoptic and paraventricular nuclei,in a water-loaded and ethanol-anesthetized rat." Neuropharmacology. (1992)
Hiromi Tsushima、Mayumi Mori 和 Tomohiro Matsuda:“强啡肽注射到下丘脑视上核和室旁核中,对水负载和乙醇麻醉的大鼠的影响。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Mayumi Mori, Hiromi Tsushima, and Tomohiro Matsuda: "Effects of substance P and its analogs in the hypothalamic vasopressinergic nucleus (supraoptic nucleus)." Neurochemistry (Japan). 28. 266-267 (1989)
Mayumi Mori、Hiromi Tsushima 和 Tomohiro Matsuda:“P 物质及其类似物对下丘脑加压素核(视上核)的影响。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
栗山 欣弥,松田 友宏: "脳と神経の薬理(改訂2版)" 金芳堂, 262 (1989)
Kinya Kuriyama、Tomohiro Matsuda:“大脑和神经的药理学(修订第 2 版)”Konpodo,262 (1989)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
29
    Development of the theory of philosophical teacher in post-war France based on Derrida's thought
    • 批准号:
      19K23028
    • 项目类别:
      Grant-in-Aid for Research Activity Start-up
    • 资助金额:
      $1.08万
    • 财政年份:
      2019
    • 负责人:
      MATSUDA Tomohiro
    • 依托单位:
    海外基金